Do-Coop Technologies Announces New Distribution Program. Establishes sales channels for its expanding Neowater™ - Enhancer product line.

Released on = May 5, 2005, 4:21 am

Press Release Author = Addi Amirav

Industry = Healthcare

Press Release Summary = Do-Coop Technologies Ltd., a privately held corporation based in Israel, announced today the launching of its new world-wide Distribution Program.

Press Release Body = Do-Coop Technologies Announces New Distribution Program. Establishes sales channels for its expanding Neowater™ - Enhancer product line.

Do-Coop Technologies Ltd., a privately held corporation based in Israel, announced today the launching of its new world-wide Distribution Program.

Do-Coop Technologies manufactures a stable system of largely hydrated nano-particles (Neowater™) for the Life Sciences. Among the recently introduced products we highlight Neowater™ - PCR Enhancer, Neowater™ - Transfection Enhancer, and Neowater™
- Transfection Enhancer. Do-Coop’s family of products, all based on Do-Coop’s proprietary Neowater™ technology, dramatically enhances existing reagents,
applications and processes to help segments of the Life Sciences industry to achieve the results they expect and need. Today.

About Neowater™

Neowater™-based products consist of a stable system of largely hydrated nano-particles that lead to several important benefits for research, diagnostics and
bio-pharma applications. The hydrated nano-particles, like non-ionic detergent derived micelles, reduce the entropy of aqueous solutions and mimic intracellular
water. In addition, by design, they exhibit hydrophobic properties.

The non-ionic Neowater™ works by coating components at their molecular level, thus exposing, increasing and/or enhancing those specific surfaces which are required for a specific reaction but are normally not available to interact (e.g. GC-rich DNA).
Therefore, very small volumes of Neowater™, and reduced component’s concentrations or amounts, are needed for a reaction when using Neowater™. Neowater™ allows for (low-volume) miniaturization of Life Sciences products, applications and processes.

Neowater™-based products significantly accelerate and improve the efficiency of biological reactions.

New Distribution Program

“Following an initial period of customer validation for our products, and the introduction of some unique products for the Research and Diagnostic markets,
Do-Coop Technologies is in the process of establishing a network of distributors to market its Neowater(TM)-based product line. Initially we will be marketing our Neowater Enhancer family of products, followed by a new line of Neowater-based Reagents and Neowater-based Diagnostic Kits,” said Eran Gabbai, founder and CTO of Do-Coop Technologies, and the inventor of Neowater™.

“We are in the process of introducing a complete product line that dramatically enhances upstream research and diagnostic processes. Our future plans include the introduction of novel downstream products such as protein expression and purification enhancers, all of which are based on Neowater™ technology,” he added.

Please visit Do-Coop’s web site for Neowater technology and product information at
www.docoop.com.

From: Ahead Business Solutions Ltd.
On Behalf of:
Do-Coop Technologies Ltd.
Email: info@docoop.com
http://www.docoop.com/

Web Site = http://www.docoop.com/

Contact Details = Ahead Business Solutions Ltd.
25 Manchester Square London
addia@ahead-bs.com